Archive - March 2019
U.S. FDA Grants Priority Review for Fedratinib New Drug Application in Myelofibrosis
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
TB Medicine Pretomanid Enters Regulatory Review Process in the United States
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Sanofi gets cardio outcomes claim for Praluent in EU
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
Allergy Tx hit hard as birch pollen product stumbles